Meet our team

In order to accelerate oncology innovation and asset commercialisation we have built a team of experts who have not only successfully achieved this in their careers to date but who are committed to contributing their experience and expertise to continued innovation and success in oncology drug development both now and in the future

The cross-functional team at Cumulus are individually and collectively exceptional scientists and entrepreneurs in the oncology area, many with successful drug development programmes to their name. This blend of scientific acumen, commercial understanding coupled with proven operational ability blends powerfully with the shared purpose of the team; to innovate in oncology drug discovery and development to ensure that only the most promising scientific discoveries are translated into new therapeutic options for cancer patients.

Board of Directors

Mr Keith Murdoch
Interim Chairman & NXD

Entrepreneur and investment strategist. Expertise in deal negotiation and M&A activities as well as investor relations, financial modelling and business management.

LinkedIn

Dr Clare Wareing
Founder & CEO

Senior Executive and entrepreneur with the vision, drive and experience of successful oncology drug development and company exits to lead the company forward. Company builder.

LinkedIn

Dr Sally Waterman
NED

Entrepreneur and biotech industry veteran with extensive drug development, commercialisation and board experience. Company builder.

LinkedIn

Dr Diane Seimetz
NED

Entrepreneur and expert in the development and commercialisation of biologics. Company builder.

LinkedIn

Dr Andrew McNeill PhD
Investor Director

Serial entrepreneur and investor in the technology and life sciences sector. Expertise in company spin-outs, deal structure, investment and exit strategies. Company builder.

LinkedIn

Clare Doris
Chief Operating Officer

A life sciences entrepreneur with a successful career in building and managing companies in the sector. Clare plays a key role in Cumulus’ ambitious growth plans.

LinkedIn

Cumulus Core Team

Dr Clare Wareing
Founder & CEO

Senior Executive and entrepreneur with the vision, drive and experience of successful oncology drug development and company exits to lead the company forward. Company builder.

LinkedIn

Clare Doris
Chief Operating Officer

A life sciences entrepreneur with a successful career in building and managing companies in the sector. Clare plays a key role in Cumulus’ ambitious growth plans.

LinkedIn

Dr Ian Waddell
Chief Scientific Officer

Oncology focussed biochemist with more than 25 years’ experience and a proven track record of drug discovery in a variety of settings including large pharma, academic and CRO. Has interests in target identification / validation and synthetic lethal and epigenetics.

LinkedIn

James Fair
Chief Financial Officer

A seasoned financial executive with a strong track record in driving financial strategies and operational excellence. Proven ability to navigate complex financial landscapes and deliver strategic solutions sets him apart as a trusted leader in the industry.

LinkedIn

Dr Tim Sparey
Chief Business Officer

Highly motivated with 22 years of experience in blue chip big pharma, specialty pharma, and biotech. Held CEO and business development positions in companies focused on neuroscience, cancer, diabetes, and ophthalmology. Notable achievements include founding start-ups, fundraising, and major partnerships with Lundbeck and GSK. A strategic leader driving innovation and success in the biopharma industry.

LinkedIn

Scott Doak
Group Finance Director

Entrepreneurial financial strategist with extensive experience of financial modelling and business management, deal negotiation and investor relations.

LinkedIn

Dr Dominic James
Executive in Residence

With over 30 years of experience in drug discovery and molecular biology. As a seasoned CRO team leader, scientific consultant and freelance editor, Dominic offers valuable expertise in oncology.

LinkedIn

Dr Thomas Wirth
Executive in Residence

Expertise in cell and gene therapy, combined with significant contributions to regulatory compliance, product development, fundraising, and operational efficiency. Proven track record in revenue generation and relationship building, establishing valuable partnerships within the industry.

LinkedIn

Dr Xavier Leroy
Executive in Residence

Xavier Leroy is a seasoned expert with over 25 years in drug discovery and clinical research, specialising in GPCRs and immunology. He has a history of advancing first-in-class drugs to clinical trials and holds significant roles in biotech development, demonstrating exceptional leadership in the biopharmaceutical sector.

LinkedIn

Dr Nikki March
Senior Director of Scientific Affairs

Highly skilled scientist, with over 20 years’ experience in the oncology area, spanning molecular signalling, signal transduction pathways and applications in drug discovery.

LinkedIn

Dr Manuelle Debunne
Director of Scientific Affairs

Entrepreneurial scientist with proven ability to manage academic and industry programs to translate oncology assets towards clinical development.

LinkedIn

Daragh Campbell
Project Manager

Entrepreneurial scientist with industrial management experience to support executive and commercial teams.

LinkedIn

Dr Tilly Bingham
Executive in Residence

Extensive experience in the pharmaceutical and biotech sectors, with a strong background in medicinal chemistry. Excels in strategic planning, managing intricate projects, and turning innovative ideas into influential products.

LinkedIn

Nazila Ghandchi
Senior Administrator

Personal Assistant and administrator with over 15+ years’ experience, who has a passion for organisation and efficiency whilst working with a diverse range of clients.

LinkedIn

We are hiring

Want to be part of a mission-led company in oncology drug development?